• Product NameDoxofylline
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityDoxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
• Target NamePDE inhibitor
• CAS No. 69975-86-6
• Calculated MW 266.26
• Formulation C11H14N4O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Respiratory system
  SMILES:CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O
  Pathways:Metabolism
  Receptor:PDE
  Boling pt:505.2C
  Melting pt:144-146C
  Solubility:Ethanol: 2 mg/mL (7.51 mM); Water: 24 mg/mL (90.14 mM); DMSO: 53 mg/mL (199.06 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Shukla D, et al. Expert Opin PharmacOthers, 2009, 10(14), 2343-2356.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting